Department of Pediatric Dentistry, Faculty of Dentistry, Chulalongkorn University, Bangkok, Thailand; Dental Biomaterials Science Program, Graduate School, Chulalongkorn University, Bangkok, Thailand.
Department of Pediatric Dentistry, Faculty of Dentistry, Chulalongkorn University, Bangkok, Thailand.
J Endod. 2017 Jul;43(7):1097-1103. doi: 10.1016/j.joen.2017.01.037. Epub 2017 May 3.
This study investigated the effects of acemannan, a polysaccharide from Aloe vera, on human deciduous pulp cells in vitro and the response after vital pulp therapy in dog deciduous teeth.
Human primary dental pulpal cells were treated with acemannan in vitro and evaluated for proliferation, alkaline phosphatase activity, type I collagen, bone morphogenetic protein (BMP-2), BMP-4, vascular endothelial growth factor, and dentin sialoprotein expression and mineralization. Osteogenesis-related gene expression was analyzed by complementary DNA microarray. Pulpal inflammation was induced in dog teeth for 14 days. The inflamed pulp was removed, retaining the healthy pulp. The teeth were randomly divided into 3 treatment groups: acemannan, mineral trioxide aggregate, and formocresol. Sixty days later, the teeth were extracted and evaluated histopathologically.
Acemannan significantly increased pulp cell proliferation, alkaline phosphatase, type I collagen, BMP-2, BMP-4, vascular endothelial growth factor, and dentin sialoprotein expression and mineralization approximately 1.4-, 1.6-, 1.6-, 5.5-, 2.6-, 3.8-, 1.8-, and 4.8-fold, respectively, compared with control. In vivo, partial pulpotomy treatment using acemannan generated outcomes similar to mineral trioxide aggregate treatment, resulting in mineralized bridge formation with normal pulp tissue without inflammation or pulp necrosis. In contrast, the formocresol group demonstrated pulp inflammation without mineralized bridge formation.
Acemannan is biocompatible with the dental pulp. Furthermore, acemannan stimulated dentin regeneration in teeth with reversible pulpitis.
本研究旨在探讨从库拉索芦荟中提取的多糖——acemannan 对体外人乳牙牙髓细胞的影响,以及在犬乳牙活髓切断术后的反应。
体外用人原代牙髓细胞处理 acemannan,并评估其增殖、碱性磷酸酶活性、I 型胶原、骨形态发生蛋白(BMP-2、BMP-4)、血管内皮生长因子和牙本质涎磷蛋白的表达和矿化情况。通过 cDNA 微阵列分析骨生成相关基因的表达。在犬牙中诱导牙髓炎症 14 天。去除发炎的牙髓,保留健康的牙髓。牙齿随机分为 3 个治疗组:acemannan、三氧化矿物凝聚体和福尔马林甲酚。60 天后,提取牙齿并进行组织病理学评估。
与对照组相比,acemannan 可使牙髓细胞增殖、碱性磷酸酶、I 型胶原、BMP-2、BMP-4、血管内皮生长因子和牙本质涎磷蛋白的表达和矿化分别增加约 1.4 倍、1.6 倍、1.6 倍、5.5 倍、2.6 倍、3.8 倍、1.8 倍和 4.8 倍。在体内,使用 acemannan 进行部分活髓切断术的治疗效果与三氧化矿物凝聚体相似,可形成矿化桥,伴有正常牙髓组织,无炎症或牙髓坏死。相比之下,福尔马林甲酚组则表现为牙髓炎症而无矿化桥形成。
acemannan 与牙髓组织具有生物相容性。此外,acemannan 可刺激可逆性牙髓炎牙齿的牙本质再生。